Showing results (161-170 of 185) with videos related to
Sort By:
Pageof 19
European Journal of Cancer & Clinical Oncology|December 1, 1982
A multicentre phase II trial of vindesine in malignant melanomaJ Carmichael, R J Atkinson, K C Calman, et al.International Journal of Cancer|July 15, 1979
Indirect leukocyte migration assay in patients with malignant melanomaL J Morrison, A J Cochran, R M Mackie, et al.British Journal of Cancer|May 31, 2001
Adjuvant interferon alpha 2b in high risk melanoma - the Scottish studyD A Cameron, M C Cornbleet, R M Mackie, et al.British Medical Journal (Clinical Research Ed.)|June 14, 1986
Benign melanocytic naevi as a risk factor for malignant melanomaA J Swerdlow, J English, R M MacKie, et al.Human Genetics|May 8, 2000
The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3G Richard, N Brown, L E Smith, et al.The British Journal of Dermatology|November 1, 1989
Novel variants of human papillomavirus type 2 in warts from immunocompromised individualsC A Wilson, S C Holmes, M S Campo, et al.The British Journal of Dermatology|February 1, 1987
Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up studyN H Cox, S K Jones, D J Downey, et al.BMJ (Clinical Research Ed.)|September 10, 1988
Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanomaA J Swerdlow, J S English, R M MacKie, et al.BMJ (Clinical Research Ed.)|December 31, 1997
Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma GroupR M MacKie, D Hole, J A Hunter, et al.British Medical Journal (Clinical Research Ed.)|January 17, 1987
Relation between phenotype and banal melanocytic naeviJ S English, A J Swerdlow, R M MacKie, et al.Pageof 19